Cva ischemic
Pro Research Analysisby 
Searched over 200M research papers for "cva ischemic"
Ischemic Cerebrovascular Accidents (CVA): Incidence, Risk Factors, and Outcomes
Incidence of Ischemic CVA in COVID-19 Patients
The COVID-19 pandemic has brought to light various complications beyond respiratory issues, including ischemic cerebrovascular accidents (CVA). A systematic review and meta-analysis revealed that the incidence of ischemic CVA in COVID-19 patients is approximately 1.7%, with a mortality rate of 29.2% among those who suffer from both conditions simultaneously . This highlights the significant risk and severe outcomes associated with ischemic CVA in the context of COVID-19.
Ischemic CVA in Takotsubo Cardiomyopathy
Takotsubo cardiomyopathy (TTC) is another condition associated with a notable incidence of ischemic CVA. Data from the National Inpatient Sample (NIS) dataset from 2007 to 2014 indicated that 4.3% of TTC cases involved CVA, with ischemic CVA accounting for 64% of these cases. Patients with ischemic CVA in this context were more likely to have preexisting conditions such as hypertension, renal failure, and diabetes . This underscores the importance of managing these risk factors to potentially reduce the incidence of ischemic CVA in TTC patients.
Ischemic CVA in Down Syndrome Patients
A study focusing on Down Syndrome (DS) patients found that ischemic CVA contributes significantly to morbidity. Among 44,720 admissions of DS patients, 355 had ischemic CVA. These patients were generally older and had higher rates of hypertension, diabetes, and peripheral vascular disease compared to those without CVA. Interestingly, the study found no significant difference in all-cause mortality between DS patients with and without CVA . This suggests that while ischemic CVA is prevalent in DS patients, it may not necessarily increase mortality rates.
Ischemic CVA in Sickle Cell Disease
Sickle cell disease (SCD) patients are at a high risk for ischemic CVA, with the highest incidence observed in children and older adults. The Cooperative Study of Sickle Cell Disease reported that the prevalence of CVA in SCD patients was 4.01%, with an incidence rate of 0.61 per 100 patient-years. Risk factors for ischemic CVA in these patients included prior transient ischemic attacks, low steady-state hemoglobin, and recent episodes of acute chest syndrome . These findings highlight the need for vigilant monitoring and management of these risk factors in SCD patients.
Hemorrhagic Transformation of Ischemic CVA
A significant complication of ischemic CVA is hemorrhagic transformation, which can worsen clinical outcomes and increase mortality. Risk factors for this transformation include age, use of antithrombotic medications, stroke severity, and hypertension. The pathogenesis involves the release of reactive oxygen species and metalloproteinases, leading to the breakdown of the extracellular matrix and subsequent hemorrhage . Understanding these mechanisms is crucial for developing strategies to prevent hemorrhagic transformation in ischemic CVA patients.
Ischemic CVA in Glioma Patients
Patients with gliomas are also at risk for ischemic CVA, particularly postoperatively. A study at the University of Texas-M.D. Anderson Cancer Center found that 0.1% of glioma patients experienced ischemic CVA, with a significant portion occurring post-surgery. The median overall survival post-stroke was significantly lower in high-grade glioma patients compared to low-grade glioma patients . This indicates the need for improved preventive measures and postoperative care in glioma patients to mitigate the risk of ischemic CVA.
Conclusion
Ischemic cerebrovascular accidents (CVA) present a significant health risk across various patient populations, including those with COVID-19, Takotsubo cardiomyopathy, Down Syndrome, sickle cell disease, and gliomas. The incidence and outcomes of ischemic CVA are influenced by multiple factors such as preexisting conditions, age, and specific disease characteristics. Effective management of risk factors and vigilant monitoring are essential to reduce the incidence and improve outcomes for patients at risk of ischemic CVA.
Sources and full results
Most relevant research papers on this topic
The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis
Ischemic cerebrovascular accidents (CVA) have a 1.7% incidence in COVID-19 patients, with a 29.2% mortality rate among those experiencing CVA.
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
Cerebrovascular accidents are more common in sickle cell anemia patients, with risk factors including prior transient ischemic attack, low steady-state hemoglobin, acute chest syndrome, and elevated systolic blood pressure.
Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center
Ischemic stroke in glioma patients is a rare complication, often associated with surgery, and negatively impacts performance status and neurologic function, with survival differences likely due to tumor grade.
Abstract WMP54: Cerebrovascular Accidents in Patients With a Left Ventricular Assist Device
Axial-flow LVADs reduce the incidence of cerebrovascular accidents compared to paracorporeal LVADs, and diabetes increases the risk of CVAs, with different effects on ischemic and hemorrhagic subtypes.
COVID‐19 and Ischemic Stroke: Clinical and Neuroimaging Findings
COVID-19 patients with ischemic cerebrovascular accidents may have atypical presentations, with increased coagulability and microangiopathy, and may require urgent neuroimaging.
Is beta-thalassemia trait a protective factor against ischemic cerebrovascular accidents?
Beta-thalassemia trait may have a protective effect against ischemic cerebrovascular accidents, possibly due to lower arterial blood pressure in those with this trait.
DOI